Stock listing
Dyne Therapeutics, Inc.
Selected listing: DYN · BX · CHF · CH
Dyne Therapeutics, Inc. (BX Swiss: DYN), Health Technology. Latest release Sep 29, 2026: Dyne Therapeutics Announces Additional One-Year Clinical Data…
- Ticker
- BX Swiss: DYN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BX Swiss
- Currency
- CHF
About Dyne Therapeutics, Inc.
The company focuses on developing innovative therapies for serious diseases, leveraging its proprietary technology platform. Dyne Therapeutics aims to address unmet medical needs through its research and development efforts.
Latest news from Dyne Therapeutics, Inc.
Dyne Therapeutics Announces Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
September 29, 2026
Dyne Therapeutics Announces Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
September 28, 2026
Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) at Upcoming Medical Meetings
September 8, 2026
Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting
September 3, 2026
Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
July 29, 2026
Research Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. company profile
View the public company page for Dyne Therapeutics, Inc. on 6ix.
Dyne Therapeutics, Inc. news
Read company news and market updates connected to Dyne Therapeutics, Inc..
Dyne Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Dyne Therapeutics, Inc..